Manchester Capital Management’s Teladoc Health TDOC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-80
| Closed | -$637 | – | 1232 |
|
|
2025
Q1 | $637 | Hold |
80
| – | – | ﹤0.01% | 1074 |
|
|
2024
Q4 | $728 | Buy |
+80
| New | +$728 | ﹤0.01% | 1060 |
|
|
2024
Q3 | – | Sell |
-97
| Closed | -$949 | – | 1194 |
|
|
2024
Q2 | $949 | Buy |
97
+51
| +111% | +$499 | ﹤0.01% | 1010 |
|
|
2024
Q1 | $695 | Buy |
46
+30
| +188% | +$453 | ﹤0.01% | 913 |
|
|
2023
Q4 | $345 | Sell |
16
-295
| -95% | -$6.36K | ﹤0.01% | 941 |
|
|
2023
Q3 | $5.78K | Hold |
311
| – | – | ﹤0.01% | 632 |
|
|
2023
Q2 | $7.88K | Hold |
311
| – | – | ﹤0.01% | 566 |
|
|
2023
Q1 | $8.06K | Sell |
311
-933
| -75% | -$24.2K | ﹤0.01% | 571 |
|
|
2022
Q4 | $29.4K | Sell |
1,244
-311
| -20% | -$7.36K | ﹤0.01% | 397 |
|
|
2022
Q3 | $39K | Sell |
1,555
-311
| -17% | -$7.8K | 0.01% | 371 |
|
|
2022
Q2 | $62K | Hold |
1,866
| – | – | 0.01% | 349 |
|
|
2022
Q1 | $135K | Hold |
1,866
| – | – | 0.02% | 297 |
|
|
2021
Q4 | $171K | Sell |
1,866
-65
| -3% | -$5.96K | 0.02% | 281 |
|
|
2021
Q3 | $245K | Sell |
1,931
-63
| -3% | -$7.99K | 0.03% | 256 |
|
|
2021
Q2 | $332K | Hold |
1,994
| – | – | 0.05% | 215 |
|
|
2021
Q1 | $362K | Sell |
1,994
-83
| -4% | -$15.1K | 0.05% | 190 |
|
|
2020
Q4 | $415K | Buy |
2,077
+53
| +3% | +$10.6K | 0.06% | 165 |
|
|
2020
Q3 | $444K | Buy |
2,024
+1,371
| +210% | +$301K | 0.07% | 147 |
|
|
2020
Q2 | $125K | Buy |
653
+638
| +4,253% | +$122K | 0.02% | 276 |
|
|
2020
Q1 | $2K | Buy |
+15
| New | +$2K | ﹤0.01% | 515 |
|
|
2019
Q2 | – | Sell |
-1,344
| Closed | -$75K | – | 639 |
|
|
2019
Q1 | $75K | Buy |
+1,344
| New | +$75K | 0.01% | 344 |
|